Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03088878
Title A Study of the Cirmtuzumab and Ibrutinib in Patients With B-Cell Lymphoid Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of California, San Diego
Indications

mantle cell lymphoma

chronic lymphocytic leukemia/small lymphocytic lymphoma

Therapies

Cirmtuzumab

Cirmtuzumab + Ibrutinib

Ibrutinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.